Connor, Clark & Lunn Investment Management Ltd. Compugen LTD Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $22 Billion
- Q2 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Compugen LTD stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 150,145 shares of CGEN stock, worth $271,762. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150,145
Previous 137,309
9.35%
Holding current value
$271,762
Previous $354,000
28.81%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CGEN
# of Institutions
75Shares Held
13.4MCall Options Held
191KPut Options Held
135K-
Silverarc Capital Management, LLC1.5MShares$2.72 Million0.72% of portfolio
-
Taylor Frigon Capital Management LLC1.31MShares$2.38 Million1.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.29MShares$2.33 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.09MShares$1.97 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C31.02MShares$1.85 Million0.0% of portfolio
About COMPUGEN LTD
- Ticker CGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,600
- Market Cap $157M
- Description
- Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...